Logo En IconLogo Mark IconIcelandic Intellectual Property Office

EP3689913

USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    10.10.2014
  • EP published:
    23.3.2022
  • EP application number:
    19210918.9
  • Max expiry date:
    9.10.2034
  • Title in English:
    USE OF A PCSK9 INHIBITOR TO TREAT HYPERLIPIDEMIA
  • Language of the patent:
    English

Timeline

Today
10.10.2014EP application
23.3.2022EP Publication

Owner

  • Name:
    Sanofi Biotechnology
  • Address:
    54 rue La Boétie, 75008 Paris, FR
  • Name:
    Regeneron Pharmaceuticals, Inc.
  • Address:
    777 Old Saw Mill River Road, Tarrytown, NY 10591, US

Inventor

  • Name:
    BACCARA-DINET, Marie
  • Address:
    75008 Paris, FR
  • Name:
    BESSAC, Laurence
  • Address:
    75008 Paris, FR
  • Name:
    CHAUDHARI, Umesh
  • Address:
    Bridgewater, NJ 08807, US
  • Name:
    HANOTIN, Corinne
  • Address:
    75008 Paris, FR
  • Name:
    PORDY, Robert C.
  • Address:
    Tarrytown, NY 10591, US
  • Name:
    SASIELA, William J.
  • Address:
    Tarrytown, NY 10591, US
  • Name:
    SCHWEMMER GIPE, Daniel A.
  • Address:
    Tarrytown, NY 10591, US

Priority

  • Number:
    201361890154 P
  • Date:
    11.10.2013
  • Country:
    US
  • Number:
    201461923103 P
  • Date:
    2.1.2014
  • Country:
    US
  • Number:
    201461955514 P
  • Date:
    19.3.2014
  • Country:
    US
  • Number:
    201462004620 P
  • Date:
    29.5.2014
  • Country:
    US
  • Number:
    201462025104 P
  • Date:
    16.7.2014
  • Country:
    US
  • Number:
    14306221
  • Date:
    31.7.2014
  • Country:
    EP
  • Number:
    201462054571 P
  • Date:
    24.9.2014
  • Country:
    US
  • Number:
    14306584
  • Date:
    9.10.2014
  • Country:
    EP

Classification

  • Categories:
    C07K 16/40, A61K 39/395, A61P 3/06

Upload documents